Physiology Research Center, Kashan University of Medical Sciences , Kashan, Iran.
Department of Community Oral Health, Dental School, Shahid Beheshti University of Medical Sciences , Tehran, Iran.
Soc Work Public Health. 2020 Oct 1;35(8):655-663. doi: 10.1080/19371918.2020.1810839. Epub 2020 Aug 30.
The aim of this study is to estimate the worldwide prevalence of suicidal ideation in multiple sclerosis patients. Two researchers selected words such as "epidemiology" or "prevalence" or "incidence" and "suicidal ideation in multiple sclerosis" and searched them as relevant keywords in international databases such as PubMed, Web of Science CINAHL, Embase, Psyc INFO, and Scopus. A point prevalence with 95% confidence interval was estimated. The variances of each study were calculated using the binomial distribution formula. Heterogeneity among the studies was tested by a Q-Cochran test with a significance level less than 0.1. Index of changes attributed to heterogeneity (I) was assessed. From among the 170 total articles found from 2011 to February 2019, we pooled and analyzed the data of eight final eligible studies, based on the inclusion criteria. The prevalence of suicidal ideation in multiple sclerosis patients was estimated as 13% (CI 95% = 0.09-0.17). A subgroup analysis was conducted based on the type of countries; it revealed that prevalence is higher in developed countries (15%; CI 95% = 0.1-0.2). Pooled worldwide prevalence of suicidal ideation in the MS population was calculated at 13% by random effect. It is recommended that training, counseling, and psychological support be used to help these patients.
本研究旨在估计多发性硬化症患者自杀意念的全球患病率。两位研究人员选择了“流行病学”或“患病率”或“发病率”和“多发性硬化症中的自杀意念”等关键词,并在 PubMed、Web of Science CINAHL、Embase、PsycINFO 和 Scopus 等国际数据库中进行了搜索。采用二项分布公式估计时点患病率及其 95%置信区间。使用 Q-Cochran 检验测试各研究之间的异质性,显著性水平小于 0.1。采用归因于异质性的变化指数(I)评估。在 2011 年至 2019 年 2 月期间从 170 篇文章中,我们根据纳入标准,对 8 项最终合格研究的数据进行了汇总和分析。多发性硬化症患者自杀意念的患病率估计为 13%(95%CI 0.09-0.17)。根据国家类型进行了亚组分析,结果表明发达国家的患病率更高(15%;95%CI 0.1-0.2)。采用随机效应计算多发性硬化症患者自杀意念的全球患病率为 13%。建议对这些患者进行培训、咨询和心理支持。